Dear Colleagues,
Following the tradition of the previous conferences held in Dubai from February 2008 to 2017, which witnessed the esteemed presence of numerous Nobel Laureates and more than 5000 eminent scientists, "The International Medicine and Biosciences Conference 2026" is poised to be another landmark event. With over 500 lectures spanning across 80 thematic sessions, alongside poster presentations and an associated exhibition, the conference promises to be a comprehensive platform for intellectual exchange. Leading scientists from academia and industry worldwide will converge to explore the latest advancements in Medicine and Biosciences.
The conference will delve into major topics such as:
From cutting-edge discussions on innovative drug discovery to the intricacies of medical imaging and in-silico drug design, the event will offer a diverse array of insights.
In the rapidly evolving landscape of drug discovery and therapy, the conference aims to provide a multitude of perspectives, addressing both the opportunities and challenges faced by scientists and medical professionals alike.
I eagerly anticipate welcoming participants to this dynamic conference, where world leaders in their respective fields will gather in the vibrant setting of Dubai. Renowned for its blend of tradition and modernity, Dubai offers a unique experience with its pristine beaches, bustling bazaars, upscale shopping centers, and culinary delights from around the globe. Accommodations in top-class hotels will ensure a comfortable stay, enhancing the overall experience of attendees.
Looking forward to your participation in this enriching event.
Professor Jean-Marie Lehn (born September 30, 1939, in Rosheim, France) is a French Chemist who earned a Ph.D. in Chemistry from the University of Strasbourg in 1963. He is a Professor at the University of Strasbourg, Institute for Advanced Study (USIAS), Emeritus Professor at the University of Strasbourg, and Honorary Professor at the Collège de France in Paris.
He received the Nobel Prize in Chemistry in 1987 for his studies on the chemical basis of "Molecular Recognition" (i.e., the way in which a receptor molecule recognizes and selectively binds a substrate), which plays a fundamental role in biological processes. Over the years, his work led to the definition of a new field of chemistry, which he called "Supramolecular Chemistry.” It deals with the complex entities formed by the association of two or more chemical species held together by intermolecular forces. Subsequently, the area developed into the chemistry of "Self-Organization" processes and, more recently, into "Constitutional Dynamic Chemistry.”
Professor Lehn founded the Institute of Supramolecular Science and Engineering (ISIS) in Strasbourg in 2002. He has been involved in a large number of public and private boards and committees and also participated in several start-up companies. As president of the non-governmental International Organization for Chemical Sciences in Development (IOCD), he aims, together with a group of dedicated colleagues, to contribute to helping chemists in developing countries.
Author of more than 1000 scientific publications and two books, Lehn is a member of many academies and institutions. He has received numerous international honors and awards, including Officer of the French National Order of Merit (1993), Grand Officer of the French Legion of Honour (2014), Österreichisches Ehrenzeichen für Wissenschaft und Kunst, (Austrian Decoration for Science and Art -first class, 2001), and the Grosses Verdienstkreuz mit Stern der Bundesrepublik Deutschland (Knight Commander's Cross of the Order of Merit of the Federal Republic of Germany - 2009), and was conferred the Order of the Rising Sun, Second Class, Gold, and Silver Star by the Government of Japan (2019).
Prof. Atta-ur-Rahman (FRS) is a Fellow of the Royal Society (London), and an Honorary Life Fellow of the Kings College Cambridge University. He is the author/editor of 300 books published by major US/European presses and has 1,200 research publications, 62 chapters in books and 15 patents to his credit. He is the Editor-in-Chief of several Chemistry journals, including Current Medicinal Chemistry. He is also the editor of a novel book series Studies in Natural Product Chemistry, being published by Elsevier Science Publishers. Eighty seven Volumes of this monumental book series have already been published.
Prof. Atta-ur-Rahman has been awarded Doctor of Science degrees by several universities, including Cambridge University and the UNESCO Science Prize (1999) as well as the highest civil awards of the governments of Pakistan, Austria and China for his contributions to medicinal chemistry and education. He has established several insititutions in different countries, such as Malaysia, China and Pakistan.
Dr. Maryam Matar is a globally recognized Emirati physician and thought leader who pioneered Longevity Medicine in the Arab world in 2011. She has since become a driving force in aligning future medicine including genomics, regenerative medicine, and predictive healthcare—with national health strategies, legislation, and infrastructure.
At just 28, she became the first female Senior Undersecretary of the UAE Ministry of Health, following the success of her volunteer health initiatives, which later shaped federal policy. She transformed zero-budget community projects into five sustainable NGOs, including UAEGDA and Emirates Down Syndrome Association, now operating at national impact levels.
Her leadership has led to six major legislative changes in the UAE, such as:
Dr. Matar also served as Director General of the Dubai Community Development Authority, managing an AED 800M budget, and led the Dubai Strategic Plan 2008–2017 for Health, Education, and National Identity. She has guided one of the largest genetic surveys in the GCC, impacting 11,000+ Emiratis.
Key Roles s Affiliations
Current Focus: Advancing translational research and consultancy in genomics, longevity, and regenerative medicine, while scaling innovative health projects globally.